Back to top

Press Releases

Zacks Equity Research

The Zacks Analyst Blog Highlights: Amgen, Cisco, NextEra Energy, AbbVie and eBay

AMGN CSCO NEE ABBV EBAY

Trades from $3

For Immediate Release

Chicago, IL – November 21, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Amgen (Nasdaq:(AMGN - Free Report) Free Report), Cisco (Nasdaq:(CSCO - Free Report) Free Report), NextEra Energy (NYSE:(NEE - Free Report) Free Report), AbbVie (NYSE:(ABBV - Free Report) –Free Report) and eBay (Nasdaq:(EBAY - Free Report) – Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday’s Analyst Blog:

Top Research Reports for Today: AMGN, CSCO, NEE

Today's Research Daily features new research reports on 16 major stocks, including Amgen (Nasdaq:(AMGN - Free Report) Free Report), Cisco (Nasdaq:(CSCO - Free Report) Free Report) and NextEra Energy (NYSE:(NEE - Free Report) Free Report).

Buy-rated Cisco has lost ground following the mixed quarterly report, but the stock is still up more than 10% in the year-to-date period and continues to lead the broader technology space. In the updated research report issued today, the Zacks analyst covering the stock highlights Cisco’s expanding footprint in the rapidly growing security and data center market. Moreover, partnerships with the likes of Pure Storage, salesforce.com and IBM will help Cisco to gain significant traction in the data center, cloud and Internet of Things (IoT) market in the long haul. (You can read the full research report on Cisco here>>)

Amgen shares have struggled this year, but it has come back following the election as fears of restrictive pricing and regulatory strictures have eased. The analyst points to Amgen’s impressive quarterly results, its portfolio of blockbuster drugs, the prospect for efficiency gains from the restructuring plan and track record of returning excess cash to shareholders through dividends and buybacks. Amgen is also progressing with its pipeline given quite a few regulatory and data updates scheduled for the coming quarters. However, the company has some challenges in store given the presence of biosimilar competition and slowdown in sales of mature products. (You can read the full research report on Amgen here>>)

NextEra Energy ’s shares have increased by more than 10% year-to-date but have struggled over the last quarter. NextEra Energy’s reported mixed third-quarter earnings. However, the analyst likes NextEra Energy's investment in renewable generation which should boost its performance over the long haul. Favorable economic conditions in its service territories will drive demand for utility services. Strategic acquisition and asset divestment bode well for NextEra Energy. On the flip side, NextEra Energy's nature of business is subject to complex and comprehensive federal, state and other regulations. Also, concerns related to commodity price fluctuations might deter its growth to some extent. (You can read the full research report on NextEra Energy here>>)

Other noteworthy reports we are featuring today include AbbVie (NYSE:(ABBV - Free Report) –Free Report) and eBay (Nasdaq:(EBAY - Free Report) – Free Report).

Today's Long-Term Buys & Sells
Today you can gain access to the best long-term trades unearthed by Zacks Research. These moves have double and triple-digit profit potential and are rarely available to the public. Starting now, you can look inside our stocks under $10, home run and value stock portfolios, plus more. Want a peek at this private information? Click here >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on AMGN - FREE

Get the full Report on CSCO - FREE

Get the full Report on NEE - FREE

Get the full Report on ABBV - FREE

Get the full Report on EBAY - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.